Why One Leader Is Calling Out Insurers’ Inaction On Prior Authorization
The current prior authorization process in U.S. healthcare constitutes a crisis, according to Jesse Ehrenfeld, immediate past president of the American Medical Association.
The current prior authorization process in U.S. healthcare constitutes a crisis, according to Jesse Ehrenfeld, immediate past president of the American Medical Association.
The law that created ASTP as a formal federal agency gave it duties such as supporting a more effective marketplace and greater competition.
Explore the mindset, cultural shifts, and training strategies that define the AI‑savvy lawyer, revealing why human judgment, standardized competence, and integrated learning—not technology alone—will shape the future of the profession.
From AI to value-based care, three VCs shared their controversial takes on healthcare during a recent panel discussion at the MedCity INVEST conference.
Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration is starting to shift the balance in favor of defenders.
Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never became a big part of the genetic testing company’s business, but it is getting a new life by joining Regeneron Genetics Center, a Regeneron subsidiary that analyzes genetic data for drug R&D.
WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn't adapt fast enough to a rapidly changing weight-loss environment spurred by the rising popularity of GLP-1s, experts said.
Grounded in authoritative content and verified at every step, Protégé is the only legal AI tool that delivers work you can trust—without exception.
Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor, and Pensions Committee on Wednesday. He faced questions on vaccines, HHS cuts, and other issues.
UnitedHealth Group announced that Andrew Witty will step down as CEO due to ‘personal reasons.’ He is being replaced by Stephen J. Hemsley, who served as the company’s CEO from 2006 to 2017.
President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower prices paid in other countries, what’s called most-favored-nation pricing. If drug companies do not lower their prices accordingly, the order proposes other strategies, such as importing drugs from other countries.
Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both payers and providers to prioritize empathy, transparency, and personalized communication.
LexisNexis sat down with John Ursin, Managing Partner at Schenck Price, to learn how the firm is using legal AI to strengthen client service and daily legal work.
Employers should review their contracts, conduct claims analyses, and more to meet their fiduciary responsibility, according to one expert.
Between 4.6 million and 5.2 million adults would lose Medicaid coverage in 2026 due to proposed work requirements, according to a new report.
The Business Group on Health is paying attention to Medicaid cuts, tariffs, threats to ERISA, and more.
The Department of Justice has filed a complaint against Aetna, Elevance Health, Humana, eHealth, GoHealth, and SelectQuote, alleging that the insurers paid illegal kickbacks to brokers to boost enrollment in their Medicare Advantage plans.
Compounding pharmacies must stop making their versions of the metabolic medicines or face FDA enforcement action.